back to Meetings page
- IMMPACT-III
- November 21-22, 2003
- Four Seasons Hotel
- Washington, DC
Co-chairs:- Dennis C. Turk, PhD (University of Washington)
- Robert H. Dworkin, PhD (University of Rochester)
- Academia Participants
- J. Hampton Atkinson, MD (University of California, San Diego)
- Charles S. Cleeland, PhD (MD Anderson Cancer Center)
- John T. Farrar, MD (University of Pennsylvania)
- Richard Gershon, PhD (Northwestern University)
- Jennifer Haythornthwaite, PhD (Johns Hopkins University)
- Alejandro R. Jadad, MD, DPhil (University of Toronto)
- Mark P. Jensen, PhD (University of Washington)
- Robert D. Kerns, PhD (Yale University)
- Michael McDermott, PhD (University of Rochester)
- Patrick McGrath, PhD (Dalhousie University)
- Dwight E. Moulin, MD (London Regional Cancer Centre, Ontario)
- Turo Nurmikko, MD, PhD (Pain Research Institute, Liverpool)
- Srinivasa Raja, MD (Johns Hopkins University)
- James P. Robinson, MD, PhD (University of Washington)
- Gerold Stucki, MD (University of Munich)
- Mark S. Wallace, MD (University of California, San Diego)
- Amanda C. Williams, PhD (St. Thomas Hospital, London)
- Kathleen W. Wyrwich, PhD (Saint Louis University)
- Government Participants
- Laurie B. Burke, RPh, MPH (US Food and Drug Administration)
- Raymond Dionne, DDS, PhD (US National Institute of Health)
- Sharon Hertz, MD (US Food and Drug Administration)
- Mitchell B. Max, MD (National Institute of Health)
- Bob A. Rappaport, MD (US Food and Drug Administration)
- Jane Scott, PhD (US Food and Drug Administration)
- Lee Simon, MD (US Food and Drug Administration)
- Jane Tollett, RN, PhD (US Department of Veterans Affairs)
- James Witter, MD, PhD (US Food and Drug Administration)
- Patient Representative
- Penney Cowan (American Chronic Pain Asssociation)
- Industry Participants
- Julie Chandler, PhD (Merck & Company)
- Rozalina Dimitrova, MD, MPH (Allergan, Inc.)
- David Kellstein, PhD (Novartis Pharmaceuticals)
- Donald C. Manning, MD, PhD (Celgene Corporation)
- Susan Martin, MSPH (Pfizer)
- Steven Quessy, PhD (GlaxoSmithKline)
- Christine Rauschkolb, MD, PhD (Schwarz Biosciences GmbH)
- Margaret Rothman, PhD (Johnson & Johnson)
- Michael A. Royal, MD, JD (Alpharma)
- Joseph W. Stauffer, DO (Abbott Laboratories)
- Thorsten von Stein, MD, PhD (NeurogesX, Inc.)
- Emmeline R. Watkins, PhD (AstraZeneca Pharmaceuticals)
- Joachim Wernicke, MD, PhD (Eli Lilly & Co.)
- Richard E. White, PhD (Endo Pharmaceuticals)